Sildenafil-associated vascular CASUALTIES.
Oguz
H
H
D006801:Humans; D008297:Male; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects; D010879:Piperazines / Q000009:adverse effects*; D011687:Purines / Q000009:adverse effects; D015356:Retinal Artery Occlusion / Q000139:chemically induced; D012170:Retinal Vein Occlusion / Q000139:chemically induced; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000009:adverse effects*; D014665:Vasodilator Agents / Q000009:adverse effects*
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate